Is vaginal bleeding occurring one week after a single 1.5 mg dose of levonorgestrel (emergency contraception) expected, and what management is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bleeding After Levonorgestrel 1.5 mg Emergency Contraception

Vaginal bleeding occurring one week after taking levonorgestrel 1.5 mg for emergency contraception is an expected and common side effect that requires reassurance but warrants pregnancy testing if the next period is delayed by more than one week.

Expected Side Effect Profile

Bleeding changes are among the most common side effects of levonorgestrel emergency contraception. According to FDA labeling, women may experience changes in their period, including periods that are heavier or lighter, or periods that are early or late 1. This includes spotting or breakthrough bleeding that can occur within the first week after taking the medication.

The timing and pattern of bleeding depends on when in the menstrual cycle the medication was taken. Research demonstrates that the earlier in the cycle levonorgestrel is taken, the more likely the next bleed is to occur early 2. Importantly, spotting occurrence does not correlate with treatment failure—there is no observable difference in spotting rates between women who became pregnant and those who did not 2.

Management Approach

Immediate Reassurance

  • Provide reassurance that bleeding changes, including spotting one week post-dose, are normal and expected
  • Explain that this does not indicate treatment failure or pregnancy

Key Monitoring Parameters

The patient needs pregnancy testing if:

  • The expected menstrual period is delayed by more than 1 week 1
  • Severe abdominal pain develops (concern for ectopic pregnancy) 1

Expected timeline for next period:

  • Should arrive at the expected time or within one week of the expected time 1
  • If menses has not begun within 21 days following treatment, evaluate for pregnancy 3

No Active Treatment Required

The bleeding irregularities associated with emergency contraception are self-limited and do not require intervention. The CDC guidelines on managing bleeding irregularities with contraception 4 focus on ongoing contraceptive methods (IUDs, implants, DMPA, CHCs), not single-dose emergency contraception, which has a different side effect profile.

Important Clinical Caveats

Rule out pregnancy if:

  • Period is >1 week late
  • Any clinical suspicion exists
  • Severe abdominal pain develops (ectopic pregnancy concern)

Counsel on contraception:

  • Levonorgestrel emergency contraception should not be used as regular birth control 1
  • Schedule follow-up to discuss ongoing contraceptive options
  • The medication does not protect against sexually transmitted infections 1

Drug interactions to consider retrospectively:

  • If the patient was taking efavirenz, rifampin, or seizure medications, the effectiveness may have been reduced 1
  • Consider alternative emergency contraception methods for future use if these medications are ongoing

Safety Profile

Levonorgestrel emergency contraception has an excellent safety profile. Systematic reviews confirm that most adverse reactions are common and not serious, with menstrual irregularities being the primary side effect 5, 6. No serious adverse events requiring intervention are expected from the bleeding itself.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.